MediPharm Labs, Vivo Cannabis Slump After Announcing All-Stock Deal
MediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX: VIVO). The merger is expected
Read moreMediPharm Labs (TSX: LABS) announced on Thursday an all-equity deal to acquire VIVO Cannabis (TSX: VIVO). The merger is expected
Read moreVivo Cannabis (TSX: VIVO) appears to be going through in-fighting in terms of the direction of the company. The firm
Read moreVIVO Cannabis Inc. (TSX: VIVO) last night reported its Q1 2021 financial and operating results. The company highlighted net revenue
Read moreVivo Cannabis (TSX: VIVO) this morning has announced the retirement of both its Chairman Paul Lucas, as well as its
Read moreIn response to the spread of COVID-19, the Canadian Federal Government introduced several programs to try and alleviate the economic
Read moreVivo Cannabis (TSX: VIVO) is the latest cannabis issuer to “streamline operations” via significant layoffs at its operations. The company
Read moreVivo Cannabis (TSX: VIVO) this morning announced that it has cancelled a proposed $5.1 million private placement of its common
Read moreVivo Cannabis (TSX: VIVO) has significant reduced its outstanding debt obligations through amendments to certain convertible debentures that remain on
Read moreVivo Cannabis (TSXV: VIVO) is officially moving to the big boards. The firm announced this morning that its common shares
Read moreThis morning, CB2 Insights (CSE: CBII) announced it has entered into an agreement with that of Vivo Cannabis Inc (TSXV:
Read more